Atea

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Atea and other ETFs, options, and stocks.

About AVIR

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. 

CEO
Jean-Pierre Sommadossi
CEOJean-Pierre Sommadossi
Employees
56
Employees56
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2012
Founded2012
Employees
56
Employees56

AVIR Key Statistics

Market cap
252.03M
Market cap252.03M
Price-Earnings ratio
-1.79
Price-Earnings ratio-1.79
Dividend yield
—
Dividend yield—
Average volume
402.48K
Average volume402.48K
High today
$3.02
High today$3.02
Low today
$2.87
Low today$2.87
Open price
$2.92
Open price$2.92
Volume
311.13K
Volume311.13K
52 Week high
$4.15
52 Week high$4.15
52 Week low
$2.46
52 Week low$2.46

People also own

Based on the portfolios of people who own AVIR. This list is generated using Robinhood data, and it’s not a recommendation.
NIO
Lucid Group
SNDL
Snap
AMC Entertainment
Plug Power
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.